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Abstract
Peroxisome biogenesis is governed by molecular machineries, which are either unique to 
peroxisomes or are partially shared with mitochondria. As peroxisomes have important 
protective functions in the cell, modulation of their number is important for human health and 
disease. Significant progress has been made towards our understanding of the mechanisms of 
peroxisome formation, revealing a remarkable plasticity of the peroxisome biogenesis 
pathway. Here we discuss most recent findings with particular focus on peroxisome 
formation in mammalian cells. 
Introduction
Peroxisomes are ubiquitous, single-membrane-bound, multifunctional organelles that play 
pivotal cooperative roles in the metabolism of cellular lipids and reactive oxygen species 
(ROS) and are essential for human health and development [1]. They show remarkable 
plasticity and responsiveness, constantly adapting their number, shape, position, and 
metabolic functions to changing physiological requirements. This requires dynamic processes 
which modulate peroxisome abundance by organelle formation (biogenesis), degradation 
(auto/pexophagy), or inheritance (cell division).
Peroxisome biogenesis disorders, which often combine loss of peroxisome function with 
altered peroxisome number and plasticity, are associated with developmental defects, 
neurodegeneration, eye problems, and hearing loss [2]. Peroxisome abundance and 
subsequent alterations in ROS levels have also been reported to influence neuronal firing and 
feeding behaviour in obese mice [3], or to protect sensory cells of the inner ear from sound 
exposure [4]. These findings highlight the importance of peroxisome plasticity and regulation 
of peroxisome number in health and disease and underline that peroxisomes, which 
contribute to ROS homeostasis, breakdown of toxic lipids and combat of pathogens, have 
important protective functions (Box 1).
The biogenesis of peroxisomes involves the formation of a peroxisomal membrane, the 
targeting and insertion of peroxisomal membrane proteins (PMPs), the import of soluble 
matrix proteins (Box 1), and the modulation of peroxisomal number, shape, and cellular 
position. These processes are governed by molecular machineries, which are either unique to 
peroxisomes or are partially shared with other organelles (Fig. 1). In recent years, a number 
of unexpected observations in different model organisms have given new twists to the 
mechanisms of peroxisome formation, evolving concepts of indirect PMP targeting, ER-
driven pre-peroxisomal vesicle formation and de novo formation of peroxisomes (reviewed in 
[5–8]). This has added complexity to the current model of peroxisome formation, and the 
challenge ahead is to build an overall understanding of the general process. Here, we do not 
pretend to untie the Gordian knot of peroxisome formation, but will discuss most recent 
findings with particular emphasis on peroxisome formation in mammalian cells.
Growth and division vs. de novo formation
It is now generally accepted that peroxisome biogenesis can occur through both the classical 
route of growth and division of pre-existing organelles, or through an alternate route of de 
novo formation of nascent peroxisomes (reviewed in [5,7]). Peroxisomal numbers are, 
however, primarily controlled by growth and division [9]. 
The de novo route of peroxisome formation was promoted by studies in yeast mutants lacking 
peroxisomes due to a loss of the membrane biogenesis factors Pex3 or Pex19. Remarkably, 
peroxisomes reappeared upon reintroduction of a functional copy of the gene. This led to a 
model where several key PMPs target the ER and sequester into pre-peroxisomal vesicles, 
which are released from the ER and can then form import-competent peroxisomes which 
grow and divide to multiply [10]. The initiation of de novo formation at the ER was, 
however, questioned, as pre-peroxisomal vesicles were also observed in yeast cells lacking 
Pex3 or Pex19; the vesicles had been overlooked because they were degraded by autophagy 
[11]. Studies in yeast have suggested a role for the reticulon-like proteins Pex30 and Pex31 in 
the generation of an ER subdomain in which pre-peroxisomal vesicles bud, supporting the ER 
origin of pre-peroxisomal vesicles [12–14].
Although the ER-derived biogenic route is controversially discussed [5–8], the ER is now 
recognized as an important contributor towards peroxisome biogenesis and peroxisomes are 
considered as semi-autonomous organelles, which depend on other organelles such as the ER 
to obtain lipids or even certain proteins [15]. The model of de novo biogenesis of 
peroxisomes has recently received another twist through studies using human fibroblasts 
from patients lacking the membrane biogenesis factors Pex3 or Pex16 which are devoid of 
peroxisomal membranes [16]. When the missing peroxin was reintroduced, Pex3 targeted 
mitochondria where it exited in pre-peroxisomal vesicles. Pex16, however, trafficked to the 
ER and was released in vesicles that appeared to fuse with the mitochondria-derived pre-
peroxisomes, thereby generating import competent, new peroxisomes. These findings point to 
a contribution of both ER and mitochondria to the de novo formation of peroxisomes in 
mammalian cells [16]. 
Although PMPs in yeast lacking peroxisomes preferentially target the ER, a Pex3 fusion 
protein containing a mitochondrial targeting signal was routed to mitochondria in Pex3-
deficient cells and induced de novo formation of mitochondria-derived import-competent 
peroxisomes. These findings suggest that mitochondria in yeast and mammalian cells can 
generate peroxisomes de novo when Pex3 targets mitochondria, and it was further 
hypothesized that natural or artificial targeting of Pex3 to any endomembrane may initiate 
peroxisome formation [17]. Therefore the key event in de novo formation may be the initial 
targeting of PMPs in the absence of peroxisomes. 
PMP targeting to multiple membranes
In contrast to yeast, many PMPs are routed to mitochondria in mammalian cells lacking 
peroxisomes. These include peroxins, but also membrane transporter and tail-anchored (TA) 
membrane proteins [18,19]. How these PMPs are inserted into the mitochondrial membrane 
is not well understood, but may involve the TOM machinery. Furthermore, peroxisomes and 
mitochondria in mammalian cells have an intimate, cooperative relationship, which includes 
dual targeting and sharing of proteins [20]. A recent study on the targeting of TA proteins 
revealed that a combination of TMD hydrophobicity and tail charge determines targeting to 
distinct organelles [19]. As only subtle changes in the tail charge were required to shift TA 
protein targeting between peroxisomes and mitochondria, it is likely that advantageous 
protein exchange was driven through mutations in targeting regions altering binding affinities 
for targeting receptors such as Pex19 during co-evolution [21]. Overlap in targeting 
information may explain why so many PMPs are routed to mitochondria in mammalian cells 
when peroxisomal membranes are absent and/or the PMP import machinery is compromised. 
The targeting properties of PMPs can differ between organisms and species resulting in 
different affinities for organelle import receptors and chaperones, and may explain the 
preferential ER or mitochondrial localization in yeast and mammalian cells. Binding affinities 
and the accessibility and abundance of import receptors may also influence direct or indirect 
targeting of PMPs under physiological conditions when peroxisomes are present [6,8,22]. For 
example, mammalian Pex3 targets directly to peroxisomes via Pex16/Pex19, as well as to the 
ER via a Pex16-dependent, Pex19-independent route [23,24]. Peroxins may also fulfil 
additional functions at the ER, and a role for Pex19 and Pex3 in coordinated biogenesis of 
lipid droplets and peroxisomes has already been proposed [25].
A detailed understanding of targeting mechanisms, how proteins are routed to multiple 
membranes and how this is regulated becomes more important in light of the recent studies 
discussed above, regarding the role of the ER and mitochondria in peroxisome formation 
([12,16]). As peroxisomal membrane biogenesis depends on only three proteins (a functional 
yeast homologue of Pex16 was recently identified [26]), the core proteins Pex3/Pex16/Pex19, 
once targeted, can exploit non-peroxisomal membranes for the generation of pre-peroxisomal 
structures delivering the initial membrane for de novo formation and subsequent recruitment 
of other PMPs. How this works, is not well understood, but roles for Pex3 and Pex19 in intra-
ER sorting and budding have been revealed in yeast [27] which may be supported by Pex30 
and Pex31 [12]. Specific proteins for a de novo pathway for peroxisomes have yet to be 
identified, and peroxins and PMPs appear to use existing machinery e.g. the ER translocon or 
GET complex to enter the ER. 
If the ER- and mitochondria-derived routes only contribute to de novo peroxisome formation 
or also have a more physiological role in replenishing existing peroxisomes with PMPs and 
lipids, remains to be established (Fig. 2). An interesting aspect for future studies may be to 
investigate if these processes are linked to or driven by quality control mechanisms at 
organelle membranes to degrade or re-localize proteins with altered location. Mitochondria-
derived vesicles, which target lysosomes for protein degradation or peroxisomes have been 
reported [28]. Preventing PMPs from aberrantly targeting mitochondria may be of particular 
relevance for mitochondrial function. In line with this, a quality control system for TA 
proteins mediated by the AAA ATPAse Msp1 in yeast (ATAD1 in mammals) has been 
reported, which allows identification and extraction of mis-localised proteins [29,30]. 
Intriguingly, Msp1 and ATAD1 both localise to mitochondria and peroxisomes [30,31] and it 
was suggested that protein selectivity could depend on organelle specific factors. 
Accordingly, Pex3 was shown to shield the TA protein Pex15 at peroxisomes inhibiting its 
removal, whilst at mitochondria Pex15 is not shielded by Pex3 and can be removed by Msp1 
[32]. If Pex3 protects peroxisomal TA proteins from Msp1-mediated degradation then 
targeting Pex3 to mitochondria could effectively override this process, allowing any mis-
targeted peroxisomal TA protein to remain at mitochondria. Quality control mechanisms for 
PMPs may also exist at the ER which, together with self-organizational phenomena of PMPs 
and lipids, may drive the formation of pre-peroxisomal vesicles. As pre-peroxisomal vesicles 
are often degraded [11,28], they may serve to route mis-localised PMPs to lysosomes or re-
route them to peroxisomes. 
Shaping the peroxisomal membrane for division
The formation of peroxisomes by growth and division from pre-existing organelles requires 
remodelling and expansion of the peroxisomal membrane through the formation of tubular 
membrane extensions which then constrict and divide into new peroxisomes [33] (Fig. 2). 
Multiplication by growth and division is an asymmetric process, which generates new 
peroxisomes via formation of a membrane compartment and subsequent import of newly 
synthesised matrix proteins [34,35] (Fig. 2). Several key proteins involved in peroxisome 
dynamics and multiplication have been identified (Fig. 1), but their coordinated interplay, 
and how these processes are regulated is not well understood. 
The membrane peroxin Pex11β, a remarkable key factor in the regulation of peroxisome 
abundance in mammals, has been linked to all stages of the growth and division process. 
Pex11β functions as a membrane-shaping protein, directly deforming and elongating the 
peroxisomal membrane prior to fission [35]. This activity depends on N-terminal amphipathic 
helices which interact with membrane lipids and on oligomerisation [36,37]. Motor-driven 
pulling forces along cytoskeletal tracks can also contribute to membrane expansion (Fig. 1) 
[38]. Pex11β also supports the assembly of the fission machinery, which is composed of the 
dynamin-like GTPase Drp1 and the membrane adaptors Mff and Fis1 at the peroxisomal 
membrane (Fig. 1) (reviewed in [33]). In addition, Pex11β functions as a GTPase activating 
protein for Drp1 during peroxisomal fission [39]. Remarkably, several key fission proteins 
such as Drp1, Mff and Fis1 are shared with mitochondria, contributing to the “peroxisome-
mitochondria connection”, which impacts on their cooperative functionality, contribution to 
diseases and promotes healthy lifespan [20,40–43]. Patients with a loss of Pex11β function 
have been identified [44,45] and present with short stature, eye problems, progressive hearing 
loss and neurological defects. The metabolic functions of peroxisomes are either not or only 
slightly affected in patients with defects in peroxisome dynamics. This suggests that the 
symptoms relate to decreased peroxisome plasticity, underlining the importance of proper 
control of peroxisome abundance for cell performance. In line with this, altered peroxisome 
abundance in Pex11β-deficient epidermal cells resulted in abnormal mitosis and organelle 
inheritance, thus affecting cell fate decisions [46]. Despite their fundamental importance to 
cell physiology, the mechanisms that mediate and regulate peroxisome membrane dynamics 
and abundance in humans are poorly understood.
Peroxisome-ER tethering
Peroxisomes are not isolated entities but are a key part of the cells “social network”. They 
communicate and share signals, metabolites and proteins with other organelles. A recent 
study used multi-spectral imaging to simultaneously visualise 6 organelles and map their 
interactions [47]. This allowed clear visualisation of the extent of interactions between 
peroxisomes and other organelles, in particular the ER and mitochondria. The molecular basis 
for the interactions between peroxisomes and mitochondria in mammalian cells remains 
unknown (although a genome-wide screening study in yeast identified a potential role for 
Pex11 [48]), but two studies independently identified peroxisomal ACBD5 and the ER 
protein VAP, as the missing factors which interact to form ER-peroxisome contact sites 
(Figs. 1,2). The ACBD5-VAP hub not only plays a role in metabolite sharing/plasmalogen 
biosynthesis but also controls peroxisomal movement and membrane expansion [49,50]. 
Ultrastructural analysis of cultured mammalian cells revealed an interaction of 70-80% of the 
peroxisomes with the ER. This may explain why only a small population of peroxisomes is 
observed to move in a microtubule-dependent manner in mammalian cells; indeed, loss of 
ACBD5 increases peroxisome motility providing a new role for a peroxisome-ER tether in 
the regulation of peroxisome movement in mammals. 
Expansion and growth of the peroxisomal membrane requires lipids which are likely 
provided by the ER in a non-vesicular pathway [51]. Defects in peroxisome division (e.g. loss 
of Mff or Drp1) result in highly elongated peroxisomes, indicating a constant transfer of 
lipids from the ER to peroxisomes. As loss of peroxisome-ER interaction was shown to 
reduce membrane expansion of elongated peroxisomes, this supports a role of peroxisome-
ER contacts in lipid transfer for peroxisome biogenesis. How lipids are transferred needs to 
be addressed in future studies. However, these observations may question a major role for 
ER-derived pre-peroxisomal vesicles in lipid transport to peroxisomes.
Mutations in ACBD5 and VAPB have both been linked to retinal dystrophy and white matter 
disease [52,53] and amyotrophic lateral sclerosis [54], suggesting a possible link between loss 
of contact sites and cell dysfunction. By analogy to mitochondria-ER contacts, which involve 
a number of different complexes, there are likely to be other peroxisome-ER tethering 
complexes. In line with this a second potential peroxisomal tethering factor ACBD4, which 
also interacts with VAPB, has been identified [55]. 
Concluding remarks
What is now clear is that the ER does play an essential role in generating new peroxisomes 
either via direct interaction at membrane contact sites and providing lipids for expansion of 
the peroxisomal membrane, allowing proliferation by growth and division, or by generating 
pre-peroxisomal vesicles which under certain conditions mature into new peroxisomes. Many 
key questions remain: how do PMPs enter and leave the ER and mitochondria? How do ER- 
and mitochondria-derived vesicles fuse and mature and how are they delivered to existing 
peroxisomes? What is the prevalence of the de novo pathway, what specific factors mediate 
it? How are lipids transferred between the ER and peroxisomes at contact sites? Despite the 
current entanglement, the global principle of peroxisome formation may be simpler than 
anticipated, and the Gordian knot of peroxisome biogenesis has yet to find its Alexander the 
Great.
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Figure legends
BOX1
Peroxisome biogenesis and function
Peroxisome biogenesis requires the generation of a membrane and subsequent targeting and 
insertion of peroxisomal membrane proteins (PMPs) into the lipid bilayer, and import of 
soluble enzymes into the peroxisomal matrix [56,57]. Unlike mitochondria, peroxisomes do 
not contain DNA or protein synthesis machinery, and have to import all soluble proteins post-
translationally from the cytosol. This supported the concept of peroxisomes as autonomous 
organelles which receive all PMPs and matrix proteins from the cytosol [58]. Observations on 
ER-mediated targeting of PMPs and de novo formation challenged the classical view linking 
peroxisome biogenesis more closely to the ER. Matrix proteins and (most) PMPs are targeted 
through largely conserved, but distinct import machineries with unique properties (Fig. 1). A 
hallmark is the import of fully folded or even oligomeric matrix proteins through a dynamic 
protein translocon [59]. The import machineries are composed of peroxins (Pex proteins), 
essential biogenesis factors, whose dysfunction can either block matrix protein import 
(resulting in empty peroxisomal membrane structures, so called “ghosts”) or membrane 
biogenesis and PMP import (e.g. loss of Pex3, Pex16, or Pex19 results in the absence of 
functional peroxisomes). As cells with Pex deficiencies are viable, they present ideal models 
to study peroxisome biogenesis. The core biogenic machinery of peroxisomes has been 
identified in yeast mutants and shown to be largely conserved across species. New peroxins 
are still discovered [26,60,61], and new roles in the combat of pathogens, cell fate decision 
and healthy ageing have been associated with peroxisomes [43,46,62,63]. Important functions 
of mammalian peroxisomes include the breakdown of fatty acids by peroxisomal β-oxidation 
(in cooperation with the mitochondrial β-oxidation pathway), the synthesis of bile acids in the 
liver, the decomposition of hydrogen peroxide by peroxisomal catalase, and the synthesis of 
ether-phospholipids (e.g. myelin sheath lipids) and docosahexaenoic acid (in cooperation 
with the ER). Mammalian peroxisomes also serve as important signalling platforms 
modulating physiological and pathological processes such as inflammation, apoptosis, 
cellular aging, cancer development, immunity, and host–pathogen interactions.
Figure 1. Schematic overview of the molecular machineries involved in the biogenesis of 
mammalian peroxisomes. Matrix protein import: After synthesis on free ribosomes, cargo 
proteins containing the peroxisomal targeting signals PTS1 or PTS2 bind to the 
corresponding cytosolic receptors Pex5 or Pex7 and form receptor-cargo complexes. The 
Pex7–cargo complex requires Pex5L, the long isoform of Pex5, for import. Import is 
achieved by a complex set of integral or peripheral PMPs that form the matrix protein import 
machinery, which mediates docking of the cargo-bound import receptor at the peroxisomal 
membrane, cargo translocation into the matrix of the organelle by a dynamic translocon, and 
export of the receptor back to the cytosol. Recycling of the receptor involves its 
ubiquitination (ub) and extraction from the membrane by an AAA-ATPase complex (Pex1, 
Pex6). Membrane assembly and insertion of PMPs (containing an mPTS) depends on 
Pex19, Pex3 and Pex16. Pex19 functions as a cycling receptor/chaperone, which binds the 
PMPs in the cytosol and interacts with Pex3 at the peroxisomal membrane. Proliferation, 
growth and division: Pex11, Pex11 and Pex11 are involved in the regulation of 
peroxisome size and number. Pex11 remodels the peroxisomal membrane, and interacts 
with the membrane adaptors Mff and Fis1, which recruit the dynamin-like fission GTPase 
Drp1 to peroxisomes, which is activated by Pex11β. Motility and Inheritance: Miro1 serves 
as membrane adaptor for the microtubule-dependent motor proteins kinesin and dynein 
[19,38,64]. Tethering: ACBD5 and ACBD4 interact with ER-resident VAPA/B to mediate 
peroxisome-ER contacts. Membrane transporter: only the ABC transporter proteins 
involved in fatty acid uptake are shown. Proteins with a dual localization to both peroxisomes 
and mitochondria are marked with an asterisk. 
Figure 2. Schematic representation of mechanisms for peroxisome formation in mammalian 
cells. Peroxisome formation by growth and division follows a multistep maturation process 
involving peroxisomal membrane remodelling and elongation, membrane constriction and 
final scission. Membrane expansion requires peroxisome-ER contact and lipid transfer, 
generating a membrane compartment which imports newly synthesized PMPs and matrix 
proteins. De novo peroxisome formation: In the absence of pre-existing peroxisomes, pre-
peroxisomal vesicles can be generated at the ER and mitochondria, which may fuse and 
mature into new import-competent peroxisomes. These newly formed peroxisomes will 
further multiply by growth and division. In the presence of peroxisomes, pre-peroxisomal 
vesicles may fuse with growing or existing peroxisomes to supply certain proteins and lipids. 
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